Product How it works Pricing Blog FAQ About Contact
BIO-RAD Laboratories

BIO-RAD Laboratories (NYSE: BIO) net income

BIO-RAD Laboratories reported a net profit of $759.9m for fiscal 2025; in fiscal 2024 it reported a net loss of $1,844m. Its net margin was 29.4%. Earnings per share were $27.87.

BIO-RAD Laboratories's best year of the last 10 was fiscal 2021. It reported a loss in 3 of those 10 years.

Net income, in millions of US dollars26.02016122.22017365.620181,75920193,81420204,2542021-3,6282022-637.32023-1,8442024759.92025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025$759.9m—29.4%$27.87
2024−$1,844m—−71.9%−$65.36
2023−$637.3m—−23.9%−$21.82
2022−$3,628m−185.3%−129.5%−$121.79
2021$4,254m+11.5%145.6%$142.33
2020$3,814m+116.9%149.8%$127.86
2019$1,759m+381.0%76.1%$58.93
2018$365.6m+199.1%16.0%$12.25
2017$122.2m+370.2%5.7%$4.12
2016$26.0m—1.3%$0.88

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

BIO-RAD Laboratories net income compared with its sector

By net income for its latest fiscal year, BIO-RAD Laboratories ranks 51st of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of BIO-RAD Laboratories, 29.4%.

RankCompanyNet incomeNet margin
49thSteris$782.3m13.2%
50thRoyalty Pharma$770.9m32.4%
51stBIO-RAD Laboratories$759.9m29.4%
52ndDaVita$746.8m5.5%
53rdZimmer Biomet$705.1m8.6%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the net income of BIO-RAD Laboratories

How much did BIO-RAD Laboratories earn in fiscal 2025?
BIO-RAD Laboratories reported a net profit of $759.9m for fiscal 2025. In fiscal 2024 it reported a net loss of $1,844m.
What are the earnings per share of BIO-RAD Laboratories?
They were $27.87 in fiscal 2025, compared with −$65.36 in fiscal 2024.
What is the net margin of BIO-RAD Laboratories?
In fiscal 2025 its net profit was 29.4% of its revenue.
What was the most profitable year for BIO-RAD Laboratories?
Of its last 10 fiscal years, fiscal 2021, with $4,254m.
Where does BIO-RAD Laboratories rank in its sector by net income?
It ranks 51st of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
Where do the figures for BIO-RAD Laboratories come from?
From the annual report (Form 10-K) that BIO-RAD Laboratories files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that BIO-RAD Laboratories files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on BIO-RAD Laboratories: the BIO-RAD Laboratories page · annual accounts · revenue.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.